Circulating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay.
NCT03981679
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
278
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
OTHER:
Biological collection
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle